Granted Patent
B2
US 8,466,146 · App. 13/679,055 · Granted Jun 18, 2013
Cyclothiocarbamate derivatives as progesterone receptor modulators
Inventors:
Puwen Zhang (Audubon, PA); Andrew Fensome (Stow, MA); Eugene A. Terefenko (Center Valley, PA); Lin Zhi (La Jolla, CA); Todd K. Jones (San Diego, CA); James P. Edwards (San Diego, CA); Christopher M. Tegley (Thousand Oaks, CA); Jay E. Wrobel (Lawrenceville, NJ); Mark A. Collins (Collegeville, PA)
Assignee:
Wyeth LLC
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Methods of using compounds which are progesterone receptor agonists for contraception and the treatment of progesterone-related maladies alone or in combination with an estrogen receptor agonist or progesterone receptor antagonist are provided. These compounds have the structure: wherein R 1 , R 2 , R 3 , R 4 , R 5 , and Q 1 are defined herein.
Claims (1)
1. A method for providing hormone replacement therapy, said method comprising delivering 5-(4,4-Dimethyl-2-thioxo-1,4-dihydro-2H-3,1-benzoxazin-6-yl)-1-methyl-1H-pyrrole-2-carbonitrile or a pharmaceutically acceptable salt thereof to a mammalian subject.
Continuity (6)
Provisional Application
60183013
· May 4, 1999